Posted by Michael Wonder on 04 Aug 2021
Kestra Medical Technologies receives FDA premarket approval for ASSURE wearable cardioverter defibrillator
3 August 2021 - Kestra Medical Technologies announced today that the company has received U.S. FDA premarket approval for the ASSURE wearable cardioverter defibrillator system.
The ASSURE wearable cardioverter defibrillator system represents the next generation of monitoring and therapy to protect patients at risk of sudden cardiac death.
